KCNA1 and neoplasm: KV11 peptide shows anti-angiogenic activity not only in vitro, but also in vivo in several animal models, including the chicken chorioallantoic membrane model, the mouse corneal micropocket angiogenesis model, and also the mouse xenograft tumor model 31.